Patent · US Active

Method for modulating insulin-independent glucose transport using teneurin C-terminal associated peptide (TCAP)

US10617736B2 · kind B2 · utility

0Cited by
1References
21Claims
0Family size

Inventors

Key dates

Filing dateJul 21, 2015
Grant dateApr 14, 2020
Priority date—
Expiry dateAug 25, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/705
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a method of increasing energy available to skeletal muscle cells comprising administering to the cells an effective amount of Tenurin C-terminal Associated Peptide (TCAP). The invention provides the use of TCAP to enhance muscle performance or recovery after injury as well as to prevent and/or treat a number of conditions including insulin resistance, type II diabetes, hypoxia and glycogen storage diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.